Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001577514 | SCV001804904 | likely pathogenic | not provided | 2024-11-19 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid(s) in a non-repeat region; This variant is associated with the following publications: (PMID: 1430199, 31904027) |
Revvity Omics, |
RCV001780410 | SCV002024514 | likely pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001780410 | SCV003283118 | uncertain significance | Multiple acyl-CoA dehydrogenase deficiency | 2022-09-20 | criteria provided, single submitter | clinical testing | This variant, c.809_811del, results in the deletion of 1 amino acid(s) of the ETFA protein (p.Val270del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs779140971, gnomAD 0.007%). This variant has been observed in individual(s) with glutaric aciduria type 2 (PMID: 1430199). ClinVar contains an entry for this variant (Variation ID: 1209001). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001780410 | SCV004194723 | likely pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2024-03-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001780410 | SCV005633278 | likely pathogenic | Multiple acyl-CoA dehydrogenase deficiency | 2024-05-31 | criteria provided, single submitter | clinical testing | |
OMIM | RCV002267117 | SCV000022872 | pathogenic | Glutaric acidemia IIa | 1992-11-01 | no assertion criteria provided | literature only |